🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The proposed study will consider the LC-MS/MS quantitative determination of...
Status
Completed
Location
The British University in Egypt
Start Date
2017-11-20
Trial ID
NCT03362398
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of omarigl...
Status
Completed
Location
Multiple Locations
Start Date
2012-10-02
Trial ID
NCT01698775
Treatments Being Tested
The study titled "Efficacy and Safety of Omarigliptin, A Weekly Dipeptidyl ...
Status
Unknown
Location
BIRDEM General Hospital
Start Date
2024-09
Trial ID
NCT06449235
The purpose of this study is to assess the safety and efficacy of omariglip...
Status
Completed
Location
Multiple Locations
Start Date
2013-01-11
Trial ID
NCT01755156
This study will examine the safety and efficacy of the addition of omarigli...
Status
Completed
Location
Multiple Locations
Start Date
2012-10-18
Trial ID
NCT01704261
Treatments Being Tested
This study will examine the efficacy of omarigliptin 25 mg once weekly comp...
Status
Completed
Location
Multiple Locations
Start Date
2016-10-17
Trial ID
NCT02906709
Treatments Being Tested
This is a 2-part study in participants with renal impairment and matched he...
Status
Completed
Location
Multiple Locations
Start Date
2011-08-08
Trial ID
NCT01407276
Treatments Being Tested
The purpose of this study is to assess the hypothesis that treatment with s...
Status
Completed
Location
Multiple Locations
Start Date
2010-10-08
Trial ID
NCT01217073
Treatments Being Tested
The purpose of this study is to evaluate the cardiovascular (CV) safety pro...
Status
Terminated
Location
Multiple Locations
Start Date
2012-10-05
Trial ID
NCT01703208
Treatments Being Tested
This is a non-inferiority study comparing omarigliptin with sitagliptin in ...
Status
Completed
Location
Multiple Locations
Start Date
2013-06-13
Trial ID
NCT01841697